By identifying the most appropriate reparative cell(s) and its source, combined with understanding alternative mechanisms of action beyond cell replacement and assessing the short-term and long-term efficacy and safety, we can advance in the quest of providing therapeutic strategies to prevent and repair neonatal lung injury.